Prognostic  ||| S:0 E:11 ||| JJ
impact  ||| S:11 E:18 ||| NN
of  ||| S:18 E:21 ||| IN
aortic  ||| S:21 E:28 ||| JJ
regurgitation  ||| S:28 E:42 ||| NN
after  ||| S:42 E:48 ||| IN
transcatheter  ||| S:48 E:62 ||| FW
aortic  ||| S:62 E:69 ||| FW
valve  ||| S:69 E:75 ||| FW
implantation  ||| S:75 E:88 ||| FW
Aortic  ||| S:88 E:95 ||| FW
regurgitation  ||| S:95 E:109 ||| FW
( ||| S:109 E:110 ||| -LRB-
AR ||| S:110 E:112 ||| NNP
)  ||| S:112 E:114 ||| -RRB-
is  ||| S:114 E:117 ||| VBZ
an  ||| S:117 E:120 ||| DT
important  ||| S:120 E:130 ||| JJ
predictor  ||| S:130 E:140 ||| NN
of  ||| S:140 E:143 ||| IN
adverse  ||| S:143 E:151 ||| JJ
prognosis  ||| S:151 E:161 ||| NN
after  ||| S:161 E:167 ||| IN
transcatheter  ||| S:167 E:181 ||| FW
aortic  ||| S:181 E:188 ||| FW
valve  ||| S:188 E:194 ||| FW
implantation  ||| S:194 E:207 ||| FW
( ||| S:207 E:208 ||| -LRB-
TAVI ||| S:208 E:212 ||| NNP
)  ||| S:212 E:214 ||| -RRB-
by  ||| S:214 E:217 ||| IN
both  ||| S:217 E:222 ||| DT
self-expanding  ||| S:222 E:237 ||| JJ
and  ||| S:237 E:241 ||| CC
balloon-expandable  ||| S:241 E:260 ||| JJ
prostheses  ||| S:260 E:271 ||| NN
and  ||| S:271 E:275 ||| CC
is  ||| S:275 E:278 ||| VBZ
predominantly  ||| S:278 E:292 ||| RB
paravalvular  ||| S:292 E:305 ||| JJ
( ||| S:305 E:306 ||| -LRB-
PV ||| S:306 E:308 ||| NNP
) ||| S:308 E:309 ||| -RRB-
.  ||| S:309 E:311 ||| .
The  ||| S:311 E:315 ||| DT
mounting  ||| S:315 E:324 ||| JJ
evidence  ||| S:324 E:333 ||| NN
for  ||| S:333 E:337 ||| IN
moderate ||| S:337 E:345 ||| JJ
/ ||| S:345 E:346 ||| CD
severe  ||| S:346 E:353 ||| JJ
PV  ||| S:353 E:356 ||| NNP
AR  ||| S:356 E:359 ||| NNP
as  ||| S:359 E:362 ||| IN
an  ||| S:362 E:365 ||| DT
independent  ||| S:365 E:377 ||| JJ
predictor  ||| S:377 E:387 ||| NN
of  ||| S:387 E:390 ||| IN
mortality  ||| S:390 E:400 ||| NN
is  ||| S:400 E:403 ||| VBZ
discussed ||| S:403 E:412 ||| VBN
.  ||| S:412 E:414 ||| .
Moreover ||| S:414 E:422 ||| RB
,  ||| S:422 E:424 ||| ,
there  ||| S:424 E:430 ||| EX
is  ||| S:430 E:433 ||| VBZ
an  ||| S:433 E:436 ||| DT
unclear  ||| S:436 E:444 ||| JJ
impact  ||| S:444 E:451 ||| NN
on  ||| S:451 E:454 ||| IN
prognosis  ||| S:454 E:464 ||| NN
of  ||| S:464 E:467 ||| IN
mild  ||| S:467 E:472 ||| JJ
PV  ||| S:472 E:475 ||| NNP
AR  ||| S:475 E:478 ||| NNP
that  ||| S:478 E:483 ||| WDT
is  ||| S:483 E:486 ||| VBZ
most  ||| S:486 E:491 ||| RBS
likely  ||| S:491 E:498 ||| JJ
the  ||| S:498 E:502 ||| DT
result  ||| S:502 E:509 ||| NN
of  ||| S:509 E:512 ||| IN
imperfect  ||| S:512 E:522 ||| JJ
assessment  ||| S:522 E:533 ||| NN
of  ||| S:533 E:536 ||| IN
this  ||| S:536 E:541 ||| DT
complication ||| S:541 E:553 ||| NN
,  ||| S:553 E:555 ||| ,
which  ||| S:555 E:561 ||| WDT
currently  ||| S:561 E:571 ||| RB
remains  ||| S:571 E:579 ||| VBZ
semi-quantitative ||| S:579 E:596 ||| JJ
.  ||| S:596 E:598 ||| .
The  ||| S:598 E:602 ||| DT
relevance  ||| S:602 E:612 ||| NN
of  ||| S:612 E:615 ||| IN
its  ||| S:615 E:619 ||| PRP$
accurate  ||| S:619 E:628 ||| JJ
quantification  ||| S:628 E:643 ||| NN
to  ||| S:643 E:646 ||| TO
reliable  ||| S:646 E:655 ||| JJ
prognostication  ||| S:655 E:671 ||| NN
is  ||| S:671 E:674 ||| VBZ
described ||| S:674 E:683 ||| VBN
,  ||| S:683 E:685 ||| ,
along  ||| S:685 E:691 ||| RB
with  ||| S:691 E:696 ||| IN
how  ||| S:696 E:700 ||| WRB
this  ||| S:700 E:705 ||| DT
data  ||| S:705 E:710 ||| NNS
might  ||| S:710 E:716 ||| MD
be  ||| S:716 E:719 ||| VB
used  ||| S:719 E:724 ||| VBN
to  ||| S:724 E:727 ||| TO
guide  ||| S:727 E:733 ||| VB
intervention  ||| S:733 E:746 ||| NN
and  ||| S:746 E:750 ||| CC
optimise  ||| S:750 E:759 ||| JJ
outcomes  ||| S:759 E:768 ||| NNS
of  ||| S:768 E:771 ||| IN
patients  ||| S:771 E:780 ||| NNS
with  ||| S:780 E:785 ||| IN
PV  ||| S:785 E:788 ||| NNP
AR ||| S:788 E:790 ||| NNP
.  ||| S:790 E:792 ||| .
